Research Paper Volume 15, Issue 19 pp 10453—10472
An immune signature to predict the prognosis of ATRX-wildtype glioma patients and guide immune checkpoint blockade therapy
Figure 2. DEGs in ATRX-wt glioma tissues with high vs. low stromal/immune scores. (A) Volcano plot showing the DEGs between the high- and low-stromal-score groups of ATRX-wt glioma tissues. (B) Heat map showing the DEGs between the high- and low-stromal-score groups of ATRX-wt glioma tissues. (C) Volcano plot showing the DEGs between the high- and low-immune-score groups of ATRX-wt glioma tissues. (D) Heat map showing the DEGs between the high- and low-immune-score groups of ATRX-wt glioma tissues. (E) Overlapping downregulated genes between the high-stromal-score and high-immune-score groups of ATRX-wt glioma tissues. (F) Overlapping upregulated genes between the high-stromal-score and high-immune-score groups of ATRX-wt glioma tissues.